Noncompetitive inhibition of human CYP2C9 in vitro by a commercial Rhodiola rosea product.

about

Assessing the Quality and Potential Efficacy of Commercial Extracts of Rhodiola rosea L. by Analyzing the Salidroside and Rosavin Content and the Electrophysiological Activity in Hippocampal Long-Term Potentiation, a Synaptic Model of Memory.

P2860

Q54970153-3BBF3E2D-62AC-49DF-B0E8-A985A84EF159

P2860

Noncompetitive inhibition of human CYP2C9 in vitro by a commercial Rhodiola rosea product.

Item

http://www.wikidata.org/entity/Q38625997

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Noncompetitive inhibition of h ...... ercial Rhodiola rosea product.

@en

type

Item

label

Noncompetitive inhibition of h ...... ercial Rhodiola rosea product.

@en

prefLabel

Noncompetitive inhibition of h ...... ercial Rhodiola rosea product.

@en

P1476

Noncompetitive inhibition of h ...... ercial Rhodiola rosea product.

@en

P2093

Bent Hellum

http://www.w3.org/2001/XMLSchema#string

Ole Kristian Forstrønen Thu

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.

Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.

Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.

Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits.

Purification of Phenylalkanoids and monoterpene glycosides from Rhodiola rosea L. roots by high-speed counter-current chromatography.

Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy.

Enzyme kinetics for clinically relevant CYP inhibition.

Comparison of cytochrome P450 2C subfamily members in terms of drug oxidation rates and substrate inhibition.

P31

scholarly article

P356

10.1002/PRP2.324

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olav Spigset

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28805981

http://www.w3.org/2001/XMLSchema#string

P932

5684854

http://www.w3.org/2001/XMLSchema#string

Noncompetitive inhibition of human CYP2C9 in vitro by a commercial Rhodiola rosea product.

about

P2860

P2860

Noncompetitive inhibition of human CYP2C9 in vitro by a commercial Rhodiola rosea product.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932